67 results match your criteria: "the Netherlands Institute of Mental Health and Addiction[Affiliation]"
Public Health
November 2024
Epidemiology, Trimbos Institute - The Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands.
JAMA Neurol
August 2024
Department of Radiology and Nuclear Medicine, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Eur Arch Psychiatry Clin Neurosci
May 2024
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
In Europe, concentrations of ∆-tetrahydrocannabinol (THC) in cannabis resin (also known as hash) have risen markedly in the past decade, potentially increasing risks of mental health disorders. Current approaches to international drug monitoring cannot distinguish between different types of cannabis resin which may have contrasting health effects due to THC and cannabidiol (CBD) content. Here, we compared concentrations of THC and CBD in different types of cannabis resin collected in Europe (either Moroccan-type, or Dutch-type).
View Article and Find Full Text PDFSleep Med
July 2024
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands; Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Electronic address:
Objective: To examine cross-sectional and longitudinal associations of various types of dietary patterns with self-reported sleep quality and with actigraphy-estimated sleep parameters in the prospective, population-based Rotterdam Study.
Methods: For each participant, scores for five different dietary patterns were derived based on food frequency questionnaires; two pre-defined scores developed to estimate adherence to the Dutch dietary guidelines and to the Mediterranean diet; and three data-driven scores indicating a prudent, unhealthy and typical Dutch diet. In 2589 participants (median age 56.
Sleep
September 2024
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Clin Exp Dermatol
August 2024
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Background: Itch, common in dermatological conditions, is often accompanied by psychological distress and reduced quality of life. However, research on the prevalence and associated factors of itch with skin conditions in general populations is limited.
Objectives: This cross-sectional study aimed to determine the lifetime prevalence of itch with skin conditions and to identify its associated factors in individuals aged > 50 years.
Neuroepidemiology
August 2024
Department of Epidemiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Introduction: Short and long self-reported sleep durations are associated with a higher risk of stroke, but the association between objective estimates of sleep and 24-h activity rhythms is less clear. We studied the association of actigraphy-estimated sleep and 24-h activity rhythms with the risk of stroke in a population-based cohort of middle-aged and elderly.
Methods: We included 1,718 stroke-free participants (mean age 62.
J Clin Endocrinol Metab
April 2024
Department of Epidemiology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Context: An association of thyroid function with mood disorders has been widely suggested, but very few studies have examined this association longitudinally.
Objective: We assessed the cross-sectional and longitudinal association between thyroid function and depression in a population-based cohort.
Methods: A total of 9471 individuals were included in cross-sectional analyses, of whom 8366 had longitudinal data.
Psychiatry Clin Neurosci
February 2024
Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Aim: Investigating what is underlying late-life depression is becoming increasingly important with the rapidly growing elderly population. Yet, the associations between plasma biomarkers of neuroaxonal damage and late-life depression remain largely unclear. Therefore, we determined cross-sectional and longitudinal associations of neurofilament light chain (NfL) with depression in middle-aged and elderly individuals, and total tau, β-amyloid 40 and 42 for comparison.
View Article and Find Full Text PDFAppl Psychol Health Well Being
May 2024
Netherlands Institute for Health Sciences (NIHES), Rotterdam, The Netherlands.
Students in health professions often face high levels of stress due to demanding academic schedules, heavy workloads, disrupted work-life balance, and sleep deprivation. Addressing stress during their education can prevent negative consequences for their mental health and the well-being of their future patients. Previous reviews on the effectiveness of mindfulness-based interventions (MBIs) focused on working health professionals or included a wide range of intervention types and durations.
View Article and Find Full Text PDFStress Health
February 2024
Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Exposure to specific stressors has been found to associate with higher adiposity in adulthood. However, the potential overlapping effects of stress domains have been overlooked, as well as the role of parenting-related stressors that mothers are widely exposed to in mid-adulthood. Therefore, we assessed the association of overlapping effects of stress domains, including parenting-related stress, with subsequent adiposity in mothers.
View Article and Find Full Text PDFJ Affect Disord
October 2023
Big Health Ltd., London, UK/San Francisco, USA; Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Background: Considerable comorbidity exists between insomnia and anxiety, and evidence shows that the benefits of CBT for insomnia extend to anxiety. Using data from two large trials of digital CBT (dCBT) for insomnia, we evaluated whether improving sleep is an effective treatment target to reduce both insomnia and anxiety symptoms in individuals with insomnia and clinically significant anxiety.
Methods: This was a controlled sub-analysis combining individual participant data from two previous randomised controlled trials of dCBT for insomnia (Sleepio).
Trials
June 2023
Department of Psychiatry and Neuropsychology and Alzheimer Center Limburg, School for Mental Health and Neuroscience (MHeNS), Maastricht University, PO Box 6166200 MD, Maastricht, The Netherlands.
Background: Informal caregivers of people with dementia are crucial in dementia care. However, they are insufficiently supported and report caregiver burdens, which urges the need for cost-effective interventions aimed at supporting caregivers. This paper presents the design of a study evaluating the effectiveness, cost-effectiveness, and cost-utility of a blended self-management program for early-stage dementia caregivers.
View Article and Find Full Text PDFPsychiatry Res
May 2023
Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Brain Center Rudolf Magnus, Utrecht, The Netherlands; Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Brain Center Rudolf Magnus, Utrecht, The Netherlands; GGNet Mental Health, Warnsveld, The Netherlands. Electronic address:
It is unknown how smoking behavior polygenic scores (PRS) relate to psychosis and psychotic symptoms. To elucidate this, genotype and phenotype data were collected from patients with schizophrenia, their unaffected siblings, and healthy controls in a six-year follow-up prospective cohort study. Associations between smoking behaviors, PRS and schizophrenia symptoms were explored using linear mixed-effect models.
View Article and Find Full Text PDFInt J Methods Psychiatr Res
March 2023
Trimbos Institute, the Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.
Objectives: NEMESIS-3 (Netherlands Mental Health Survey and Incidence Study-3) is a psychiatric epidemiological cohort study of the Dutch general population that replicates and expands on two previous NEMESIS-studies conducted in 1996-1999 and 2007-2018 respectively. The main aims of NEMESIS-3 are to provide up-to-date information on the prevalence, incidence, course and consequences of mental disorders, their risk indicators, and to study the relevant time trends. This paper gives an overview of the objectives and methods of NEMESIS-3, especially of the recently completed first wave, and describes the sample characteristics.
View Article and Find Full Text PDFBMC Psychiatry
July 2022
Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Van der Boechorststraat 7, NL-1081 BT, Amsterdam, The Netherlands.
Background: Individual Placement and Support (IPS) is an evidence-based, effective approach to help people with severe mental illness (SMI) obtain and maintain competitive employment. The aim of the present study was to examine employment outcomes and associations with an organizational and a financial factor in people with SMI who participated in Individual Placement and Support using a multifaceted implementation strategy (IPS + MIS). The goal of this strategy was to improve IPS implementation by enhancing collaboration among mental health care and vocational rehabilitation stakeholders, and realizing secured IPS funding.
View Article and Find Full Text PDFLancet Psychiatry
August 2022
Department of Research, Arkin, Amsterdam, Netherlands; Vrije Universiteit Department Clinical Psychology, Amsterdam, The Netherlands.
BMC Psychiatry
March 2022
Department of Clinical Psychological Science, Faculty of Psychology and Neuroscienc, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Int J Drug Policy
April 2022
Clinical Psychopharmacology Unit, University College London, 1-19 Torrington Place, London, WC1E 7HB, United Kingdom.
Background: Esketamine was licensed for use in treatment resistant depression by the European Medicines Agency in December 2019. It is unclear whether this new approval has lowered the risk perception of recreational ketamine use. This is important given a recent increase in recreational ketamine use.
View Article and Find Full Text PDFEur Addict Res
March 2022
Clinical Psychopharmacology Unit, University College London, London, United Kingdom,
Background: Monitoring emerging trends in the increasingly dynamic European drug market is vital; however, information on change at the individual level is scarce. In the current study, we investigated changes in drug use over 12 months in European nightlife attendees.
Method: In this longitudinal online survey, changes in substances used, use frequency in continued users, and relative initiation of use at follow-up were assessed for 20 different substances.
Front Psychol
September 2021
Department of Psychiatry, Amsterdam UMC, and Amsterdam Institute for Addiction Research, University of Amsterdam, Amsterdam, Netherlands.
Background: Digital self-help interventions for reducing the use of alcohol tobacco and other drugs (ATOD) have generally shown positive but small effects in controlling substance use and improving the quality of life of participants. Nonetheless, low adherence rates remain a major drawback of these digital interventions, with mixed results in (prolonged) participation and outcome. To prevent non-adherence, we developed models to predict success in the early stages of an ATOD digital self-help intervention and explore the predictors associated with participant's goal achievement.
View Article and Find Full Text PDFBMC Psychiatry
May 2021
Department of Research, Arkin Mental Health Care, Amsterdam, The Netherlands.
Background: Depressive disorders and problematic drinking often co-occur, also among young adults. These co-occurring conditions are associated with various negative health outcomes compared to both conditions alone. Early intervention by addressing alcohol use and depressive symptoms simultaneously in the same treatment might improve both conditions.
View Article and Find Full Text PDFBMC Psychiatry
April 2021
Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health research institute, Van der Boechorststraat 7, NL-1081, BT, Amsterdam, The Netherlands.
Background: Individual Placement and Support (IPS) is an evidence-based, effective approach to help people with severe mental illness (SMI) achieve competitive employment. The aim of the present study is to explore experiences with Individual Placement and Support using a multifaceted implementation strategy (IPS + MIS), and competitive employment. The goal of this strategy was to improve IPS implementation by enhancing collaboration between mental health care and vocational rehabilitation stakeholders, and realizing a secured IPS funding with a 'pay for performance' element.
View Article and Find Full Text PDFBMC Psychiatry
March 2021
Department of Clinical Research, Unit of Clinical Alcohol Research, University of Southern Denmark, Odense, Denmark.
Background: A major challenge to psychological treatment for alcohol use disorder (AUD) is patient non-compliance. A promising new treatment approach that is hypothesized to increase patient compliance is blended treatment, consisting of face-to-face contact with a therapist combined with modules delivered over the internet within the same protocol. While this treatment concept has been developed and proven effective for a variety of mental disorders, it has not yet been examined for AUD.
View Article and Find Full Text PDFAlcohol Alcohol
January 2022
Department of Research, Arkin Mental Health Care, 1033 NN Amsterdam, The Netherlands.
Aims: This systematic review and meta-analysis assessed the effectiveness of digital interventions addressing depressive symptoms and alcohol use simultaneously among people with co-occurring depression and problematic alcohol use.
Methods: Seven databases were searched for trials evaluating digital interventions aimed at depression and alcohol use. Random-effects meta-analyses were conducted to pool effects on depressive symptoms and alcohol use up to 3-month and 6-month follow-up.